Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended December 31, 2012
or
¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File Number: 000-33283
THE ADVISORY BOARD COMPANY
(Exact name of registrant as specified in its charter)
Delaware | 52-1468699 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | |
2445 M Street, NW, Washington, D.C. | 20037 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (202) 266-5600
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.:
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
As of February 1, 2013, the registrant had outstanding 35,108,996 shares of Common Stock, par value $0.01 per share.
Table of Contents
INDEX TO FORM 10-Q
Page No. | ||||||
1 | ||||||
ITEM 1. | 1 | |||||
Consolidated Balance Sheets as of December 31, 2012 (unaudited) and March 31, 2012 | 1 | |||||
2 | ||||||
3 | ||||||
Unaudited Consolidated Statements of Cash Flows for the Nine Months Ended December 31, 2012 and 2011 | 4 | |||||
5 | ||||||
ITEM 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 17 | ||||
ITEM 3. | 25 | |||||
ITEM 4. | 25 | |||||
25 | ||||||
ITEM 1A. | 25 | |||||
ITEM 2. | 25 | |||||
ITEM 6. | 26 | |||||
27 |
Table of Contents
Item 1. | Financial Statements. |
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
December 31, 2012 | March 31, 2012 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 81,743 | $ | 60,642 | ||||
Marketable securities, current | 16,792 | 4,823 | ||||||
Membership fees receivable, net | 367,880 | 281,584 | ||||||
Prepaid expenses and other current assets | 8,625 | 6,705 | ||||||
Deferred income taxes, current | 8,888 | 7,255 | ||||||
|
|
|
| |||||
Total current assets | 483,928 | 361,009 | ||||||
Property and equipment, net | 65,344 | 49,653 | ||||||
Intangible assets, net | 33,353 | 19,384 | ||||||
Goodwill | 95,427 | 74,235 | ||||||
Deferred incentive compensation and other charges | 63,263 | 53,369 | ||||||
Deferred income taxes, net of current portion | 3,908 | 7,655 | ||||||
Investment in unconsolidated entity | 4,076 | 8,662 | ||||||
Other non-current assets | 6,390 | 9,000 | ||||||
Marketable securities, net of current portion | 117,980 | 122,621 | ||||||
|
|
|
| |||||
Total assets | $ | 873,669 | $ | 705,588 | ||||
|
|
|
| |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Deferred revenue, current | $ | 396,000 | $ | 313,958 | ||||
Accounts payable and accrued liabilities | 61,122 | 57,529 | ||||||
Accrued incentive compensation | 18,646 | 18,691 | ||||||
|
|
|
| |||||
Total current liabilities | 475,768 | 390,178 | ||||||
Deferred revenue, net of current portion | 112,948 | 78,498 | ||||||
Other long-term liabilities | 18,928 | 19,865 | ||||||
|
|
|
| |||||
Total liabilities | 607,644 | 488,541 | ||||||
|
|
|
| |||||
Redeemable noncontrolling interest | 100 | — | ||||||
The Advisory Board Company’s stockholders’ equity: | ||||||||
Preferred stock, par value $0.01; 5,000,000 shares authorized, zero shares issued and outstanding | — | — | ||||||
Common stock, par value $0.01; 135,000,000 shares authorized, 35,087,845 and 46,994,560 shares issued as of December 31, 2012 and March 31, 2012, respectively, and 35,087,845 and 33,729,780 shares outstanding as of December 31, 2012 and March 31, 2012, respectively | 351 | 235 | ||||||
Additional paid-in capital | 360,943 | 315,648 | ||||||
Retained (deficit) earnings | (97,208 | ) | 189,742 | |||||
Accumulated elements of other comprehensive income | 1,947 | 1,206 | ||||||
Treasury stock, at cost, 0 and 13,264,780 shares as of December 31, 2012 and March 31, 2012, respectively | — | (289,784 | ) | |||||
|
|
|
| |||||
Total stockholders’ equity controlling interest | 266,033 | 217,047 | ||||||
Equity attributable to noncontrolling interests | (108 | ) | — | |||||
|
|
|
| |||||
Total stockholders’ equity | 266,025 | 217,047 | ||||||
|
|
|
| |||||
Total liabilities and stockholders’ equity | $ | 873,669 | $ | 705,588 | ||||
|
|
|
|
The accompanying notes are an integral part of these consolidated balance sheets.
1
Table of Contents
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Revenue | $ | 116,231 | $ | 98,458 | $ | 331,131 | $ | 269,862 | ||||||||
Costs and expenses: | ||||||||||||||||
Cost of services, excluding depreciation and amortization | 63,123 | 51,501 | 178,478 | 144,415 | ||||||||||||
Member relations and marketing | 21,826 | 18,400 | 62,431 | 54,770 | ||||||||||||
General and administrative | 16,567 | 12,385 | 45,678 | 35,094 | ||||||||||||
Depreciation and amortization | 5,223 | 3,662 | 13,739 | 10,112 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating income | 9,492 | 12,510 | 30,805 | 25,471 | ||||||||||||
Other income, net | 738 | 1,625 | 2,002 | 2,870 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations before provision for income taxes and equity in loss of unconsolidated entity | 10,230 | 14,135 | 32,807 | 28,341 | ||||||||||||
Provision for income taxes | (3,918 | ) | (5,612 | ) | (12,565 | ) | (10,939 | ) | ||||||||
Equity in loss of unconsolidated entity | (1,870 | ) | (609 | ) | (4,586 | ) | (609 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income from continuing operations | 4,442 | 7,914 | 15,656 | 16,793 | ||||||||||||
Discontinued operations: | ||||||||||||||||
Net income from discontinued operations | — | 138 | — | 333 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income before allocation to noncontrolling interest | 4,442 | 8,052 | 15,656 | 17,126 | ||||||||||||
Net loss attributable to noncontrolling interest | — | — | 108 | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income attributable to common stockholders | $ | 4,442 | $ | 8,052 | $ | 15,764 | $ | 17,126 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings per share—basic: | ||||||||||||||||
Net income from continuing operations attributable to common stockholders | $ | 0.13 | $ | 0.24 | $ | 0.46 | $ | 0.52 | ||||||||
Net loss from discontinued operations attributable to common stockholders | $ | — | $ | 0.00 | $ | — | $ | 0.01 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income attributable to common stockholders per share—basic | $ | 0.13 | $ | 0.24 | $ | 0.46 | $ | 0.53 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings per share—diluted: | ||||||||||||||||
Net income from continuing operations attributable to common stockholders | $ | 0.12 | $ | 0.23 | $ | 0.44 | $ | 0.49 | ||||||||
Net loss from discontinued operations attributable to common stockholders | $ | — | $ | 0.00 | $ | — | $ | 0.01 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income attributable to common stockholders per share—diluted | $ | 0.12 | $ | 0.23 | $ | 0.44 | $ | 0.50 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Weighted average number of shares outstanding: | ||||||||||||||||
Basic | 34,949 | 32,952 | 34,597 | 32,596 | ||||||||||||
Diluted | 36,385 | 34,938 | 36,231 | 34,368 |
The accompanying notes are an integral part of these consolidated financial statements.
2
Table of Contents
UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Net income attributable to common stockholders | $ | 4,442 | $ | 8,052 | $ | 15,764 | $ | 17,126 | ||||||||
Other comprehensive income: | ||||||||||||||||
Net unrealized gains on marketable securities, net of tax | (366 | ) | 556 | 741 | 2,232 | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Comprehensive income | $ | 4,076 | $ | 8,608 | $ | 16,505 | $ | 19,358 | ||||||||
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
3
Table of Contents
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Nine Months Ended December 31, | ||||||||
2012 | 2011 | |||||||
Cash flows from operating activities: | ||||||||
Net income before allocation to noncontrolling interest | $ | 15,656 | $ | 17,126 | ||||
Adjustments to reconcile net income before allocation to noncontrolling interest to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 13,739 | 10,660 | ||||||
Deferred income taxes | (1,335 | ) | (1,914 | ) | ||||
Excess tax benefits from stock-based awards | (11,755 | ) | (2,796 | ) | ||||
Stock-based compensation expense | 10,383 | 8,462 | ||||||
Amortization of marketable securities premiums | 1,472 | 850 | ||||||
Loss (gain) on investment in common stock warrants | 110 | (1,100 | ) | |||||
Equity in loss of unconsolidated entity | 4,586 | 609 | ||||||
Changes in operating assets and liabilities: | ||||||||
Membership fees receivable | (84,582 | ) | (85,777 | ) | ||||
Prepaid expenses and other current assets | (1,772 | ) | 1,262 | |||||
Deferred incentive compensation and other charges | (9,894 | ) | (8,404 | ) | ||||
Deferred revenues | 115,486 | 105,312 | ||||||
Accounts payable and accrued liabilities | 27,543 | 13,228 | ||||||
Acquisition-related earn-out payments | (3,011 | ) | — | |||||
Accrued incentive compensation | (45 | ) | 3,250 | |||||
Other long-term liabilities | (3,437 | ) | 6,425 | |||||
|
|
|
| |||||
Net cash provided by operating activities | 73,144 | 67,193 | ||||||
|
|
|
| |||||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | (25,379 | ) | (22,650 | ) | ||||
Capitalized external use software development costs | (2,555 | ) | (2,010 | ) | ||||
Cash paid for acquisitions, net of cash acquired | (31,887 | ) | (16,829 | ) | ||||
Investment in unconsolidated entity | — | (10,000 | ) | |||||
Redemptions of marketable securities | 35,220 | 16,000 | ||||||
Purchases of marketable securities | (42,889 | ) | (31,748 | ) | ||||
|
|
|
| |||||
Net cash used in investing activities | (67,490 | ) | (67,237 | ) | ||||
|
|
|
| |||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of common stock from exercise of stock options | 21,580 | 22,980 | ||||||
Withholding of shares to satisfy minimum employee tax withholding for vested restricted stock units | (3,844 | ) | (1,266 | ) | ||||
Proceeds from issuance of common stock under employee stock purchase plan | 255 | 162 | ||||||
Excess tax benefits from stock-based awards | 11,755 | 2,796 | ||||||
Contributions from noncontrolling interest | 100 | — | ||||||
Acquisition-related earn-out payments | (1,400 | ) | — | |||||
Purchases of treasury stock | (12,999 | ) | (6,580 | ) | ||||
|
|
|
| |||||
Net cash provided by financing activities | 15,447 | 18,092 | ||||||
|
|
|
| |||||
Net increase in cash and cash equivalents | 21,101 | 18,048 | ||||||
Cash and cash equivalents, beginning of period | 60,642 | 30,378 | ||||||
|
|
|
| |||||
Cash and cash equivalents, end of period | $ | 81,743 | $ | 48,426 | ||||
|
|
|
|
The accompanying notes are an integral part of these consolidated statements.
4
Table of Contents
THE ADVISORY BOARD COMPANY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Business description and basis of presentation
The Advisory Board Company (individually and collectively with its subsidiaries, the “Company”) provides best practices research and analysis, business intelligence and software tools, and management and advisory services to hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, colleges, universities, and other educational institutions through discrete programs. Members of each program are typically charged a fixed annual fee and have access to an integrated set of services that may include best practices research studies, executive education seminars, customized research briefs, web-based access to the program’s content database, and software tools.
The unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for reporting on Form 10-Q. Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes as reported in the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2012 and the Company’s quarterly report on Form 10-Q for subsequent quarters. The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of all significant intercompany transactions. Certain prior-period amounts have been reclassified to conform to the current-period presentation.
In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the consolidated financial position, results of operations, and cash flows as of the dates and for the periods presented have been included. The consolidated balance sheet presented as of March 31, 2012 has been derived from the financial statements that have been audited by the Company’s independent registered public accounting firm. The consolidated results of operations for the three and nine months ended December 31, 2012 may not be indicative of the results that may be expected for the Company’s fiscal year ending March 31, 2013, or any other period.
On June 18, 2012, the Company completed a two-for-one split of its outstanding shares of common stock in the form of a stock dividend. Each stockholder of record received one additional share of common stock for each share of common stock owned at the close of business on May 31, 2012. Share numbers and per share amounts presented in the accompanying consolidated financial statements and notes thereto for dates before June 18, 2012 have been restated to reflect the impact of the stock split.
Reclassification
On April 1, 2012, the Company began including amortization expense for intangible assets in depreciation and amortization rather than in cost of services on its consolidated statements of income. Amounts reported for prior years have been reclassified to conform to the current period’s presentation. As a result of this reclassification, amortization expense for intangible assets of $1.6 million and $4.0 million for the three and nine months ended December 31, 2012, respectively, and $1.4 million and $3.8 million for the three and nine months ended December 31, 2011, respectively, is included in depreciation and amortization on the accompanying consolidated statements of income.
Note 2. Recent accounting pronouncements
Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB’s Accounting Standards Codification. The Company considers the applicability and impact of all recent ASUs. ASUs not listed below were assessed and determined to be not applicable or are expected to have minimal impact on the Company’s consolidated financial position and results of operations.
Recently adopted
In October 2012, the FASB issued a Technical Corrections and Improvements update which relates to various topics throughout the Codification and provides technical corrections, clarification, and limited-scope improvements. This guidance was effective upon issuance of the update, with the exception of sections that include transition guidance, which become effective for fiscal periods beginning after December 15, 2013. The adoption of this guidance did not have a material impact on the Company’s consolidated financial position, results of operations, or cash flows.
In June 2011, the FASB issued accounting guidance related to the presentation of comprehensive income which requires an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements and eliminates
5
Table of Contents
the option to present the components of other comprehensive income as part of the statement of equity. This guidance was amended in December 2011 to defer the requirements that companies present reclassification adjustments out of accumulated other comprehensive income on the face of the financial statements. This guidance was effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2011. The Company adopted these requirements on April 1, 2012 and has presented consolidated net income and consolidated comprehensive income in two separate, but consecutive, statements. While the adoption of this guidance impacted the Company’s disclosures, it did not have an impact on the Company’s financial position or results of operations.
Note 3. Marketable securities
The aggregate value, amortized cost, gross unrealized gains, and gross unrealized losses on available-for-sale marketable securities are as follows (in thousands):
As of December 31, 2012 | ||||||||||||||||
Fair market value | Amortized cost | Gross unrealized gains | Gross unrealized losses | |||||||||||||
U.S. government-sponsored enterprises | $ | 20,632 | $ | 20,508 | $ | 124 | $ | — | ||||||||
Tax exempt obligations of states | 114,140 | 111,310 | 3,104 | 274 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 134,772 | $ | 131,818 | $ | 3,228 | $ | 274 | |||||||||
|
|
|
|
|
|
|
|
As of March 31, 2012 | ||||||||||||||||
Fair market value | Amortized cost | Gross unrealized gains | Gross unrealized losses | |||||||||||||
U.S. government-sponsored enterprises | $ | 33,472 | $ | 33,543 | $ | 130 | $ | 201 | ||||||||
Tax exempt obligations of states | 93,972 | 92,028 | 2,667 | 723 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 127,444 | $ | 125,571 | $ | 2,797 | $ | 924 | |||||||||
|
|
|
|
|
|
|
|
The following table summarizes marketable securities maturities (in thousands):
As of December 31, 2012 | ||||||||
Fair market value | Amortized cost | |||||||
Matures in less than 1 year | $ | 16,792 | $ | 16,468 | ||||
Matures after 1 year through 5 years | 34,782 | 33,687 | ||||||
Matures after 5 years through 20 years | 83,198 | 81,663 | ||||||
|
|
|
| |||||
$ | 134,772 | $ | 131,818 | |||||
|
|
|
|
Other than redemptions upon maturity or calls, there were no sales of marketable securities during the three or nine months ended December 31, 2012 or 2011. The weighted average maturity on all marketable securities held by the Company as of December 31, 2012 was approximately 5.7 years. Pre-tax net unrealized gains on the Company’s investments of $3.0 million as indicated above were caused by the continued decrease in market interest rates compared to the average interest rate of the Company’s marketable securities portfolio. Of this amount, $324,000 is related to investments that mature before December 31, 2013. The Company purchased certain of its investments at a premium or discount to their relative fair values. The Company does not intend to sell these investments and it is not more likely than not that it will be required to sell the investments before recovery of the amortized cost bases, which may be maturity. The Company does not consider these investments to be other-than-temporarily impaired as of December 31, 2012. The Company has reflected the net unrealized gains and losses, net of tax, in accumulated other comprehensive income on the accompanying consolidated balance sheets. The Company uses the specific identification method to determine the cost of marketable securities that are sold.
Note 4. Acquisitions
ActiveStrategy
On October 1, 2012, the Company acquired for cash all of the issued and outstanding capital stock of ActiveStrategy, Inc. (“ActiveStrategy”), a Philadelphia-based performance improvement technology and consulting firm with innovative solutions for tracking and augmenting organizational effectiveness, for a total purchase price of $14.9 million, net of cash acquired. The total purchase price consists of an initial payment of $12.6 million and an additional $2.3 million that has been placed into escrow and will be released if specified indemnity conditions are satisfied.
6
Table of Contents
The total purchase price was preliminarily allocated to the assets acquired, including intangible assets and liabilities assumed, based on their estimated fair values as of October 1, 2012. The Company’s fair value of identifiable tangible and intangible assets was determined by using estimates and assumptions in combination with a valuation using an income approach from a market participant perspective. Of the total estimated purchase price, $1.5 million was allocated to net acquired tangible assets, which consist of accounts receivable of $1.3 million, deferred tax assets, net of $0.9 million, and other current assets of $0.3 million, netted by $1.0 million of acquired deferred revenues. Of the total estimated purchase price, $5.5 million was allocated to intangible assets, which consist of the value assigned to acquired technology related intangibles of $3.0 million, customer relationship and employee related intangibles of $1.0 million, and trademarks of $1.5 million. The acquired intangible assets have estimated lives ranging from four years to eleven years based on the cash flow estimates used to create the valuation models of each identifiable asset with a weighted average amortization period of 7.2 years. Approximately $7.9 million was allocated to goodwill, which represents synergistic benefits expected to be generated from scaling ActiveStrategy’s offerings across the Company’s large membership base. The Company is in the process of finalizing the valuation of certain intangible assets. In addition, the amount recognized for deferred tax liabilities may be impacted by the determination of these items.
The financial results of ActiveStrategy are included in the Company’s consolidated financial statements from the date of acquisition. Pro forma financial information for this acquisition has not been presented because the effects were not material to the Company’s historical consolidated financial statements.
360Fresh
On November 15, 2012, the Company acquired for cash all of the issued and outstanding capital stock of 360Fresh, Inc. (“360Fresh”), a provider of clinical data analytics. The transaction enhances the Company’s existing suite of physician performance management solutions through the addition of unique technology that transforms the data from medical records into actionable insights to improve patient quality, reduce costs, and enhance productivity for health systems. The total purchase price, net of cash acquired, of $19.5 million consisted of an initial payment of $13.6 million of cash, the fair value of estimated additional contingent cash payments of $2.5 million, and an additional $3.4 million placed into escrow, which will be released if specified indemnity conditions are satisfied. The contingent cash payments, which may not exceed $8 million and have no guaranteed minimum, will become due and payable to the former stockholders of 360Fresh if certain revenue targets are achieved over evaluation periods beginning at the acquisition date and extending through August 15, 2014.
The total purchase price was preliminarily allocated to the assets acquired, including intangible assets and liabilities assumed, based on their estimated fair values as of November 15, 2012. The Company’s fair value of identifiable tangible and intangible assets was determined by using estimates and assumptions in combination with a valuation using an income approach from a market participant perspective. Of the total estimated purchase price, $0.4 million was allocated to acquired accounts receivable and $4.1 million was allocated to assumed liabilities, which consist of $4.0 million of deferred tax liabilities and $0.1 million of acquired deferred revenue. Of the total estimated purchase price, $9.9 million was allocated to intangible assets, which consist of the value assigned to acquired technology related intangibles of $9.8 million, and employee related intangibles of $0.1 million. The acquired technology and employee related intangibles have estimated lives ranging from four years to seven years based on the cash flow estimates used to create the valuation models of each identifiable asset with a weighted average amortization period of 7.0 years. Approximately $13.3 million was allocated to goodwill, which represents synergistic benefits expected to be generated from scaling 360Fresh’s offerings across the Company’s large membership base. The Company is in the process of finalizing the valuation of certain intangible assets. In addition, the amount recognized for deferred tax liabilities may be impacted by the determination of these items.
The financial results of 360Fresh are included in the Company’s consolidated financial statements from the date of acquisition. Pro forma financial information for this acquisition has not been presented because the effects were not material to the Company’s historical consolidated financial statements.
PivotHealth
On August 1, 2011, the Company acquired for cash substantially all the assets of PivotHealth, LLC (“PivotHealth”), a leading physician practice management firm. The Company acquired PivotHealth to supplement its existing physician practice management capabilities and provide new growth opportunities with the addition of PivotHealth’s expertise in long-term physician practice management. The total purchase price, net of cash acquired, of $19.8 million consisted of an initial payment of $15.0 million of cash; the fair value of estimated additional, contingent cash payments of $2.9 million; and an additional $1.9 million placed into escrow, which was released on August 1, 2012. The contingent cash payments, which have no guaranteed minimum or maximum, will
7
Table of Contents
become due and payable to the former owner of the PivotHealth business if certain revenue targets are achieved over evaluation periods beginning at the acquisition date and extending through December 31, 2014. A $0.4 million downward adjustment was made to the fair value of the liabilities for such contingent cash payments during the three months ended June 30, 2012. A $0.1 million upward adjustment was made to the fair value of the liabilities for such contingent cash payments during the three months ended September 30, 2012. A $0.1 million upward adjustment was made to the fair value of the liabilities for such contingent cash payments during the three months ended December 31, 2012. These adjustments were recorded in cost of services on the accompanying consolidated statements of income. See Note 10, “Fair value measurements,” for additional information.
The total purchase price was allocated to the assets acquired, including intangible assets and liabilities assumed, based on their estimated fair values as of August 1, 2011. The Company’s fair value of identifiable tangible and intangible assets was determined by using estimates and assumptions in combination with a valuation using an income approach from a market participant perspective. Of the total estimated purchase price, $1.8 million was allocated to acquired tangible assets, $1.0 million was allocated to assumed liabilities, and $6.4 million was allocated to intangible assets, which consist of the value assigned to customer related intangibles of $6.0 million, primarily customer relationships and trademarks, and employee related intangibles of $0.4 million. The acquired customer and employee related intangibles have estimated lives ranging from six months to nine years based on the cash flow estimates used to create the valuation models of each identifiable asset with a weighted average amortization period of 6.5 years. Approximately $12.6 million was allocated to goodwill, which represents synergistic benefits expected to be generated from scaling PivotHealth’s offerings across the Company’s large membership base. Goodwill is deductible for tax purposes.
The financial results of PivotHealth are included in the Company’s consolidated financial statements from the date of acquisition. Pro forma financial information for this acquisition has not been presented because the effects were not material to the Company’s historical consolidated financial statements.
Note 5. Investment in unconsolidated entity
On August 31, 2011, the Company entered into an agreement with UPMC to establish Evolent Health, Inc. (“Evolent”) for the purpose of driving provider-led, value-driven care with innovative technology, integrated data and analytics, and services. The Company provided $10.0 million and other non-cash contributions to Evolent for an initial equity interest of 44% and the right to appoint one person to Evolent’s board of directors. In addition, a member of the Company’s Board of Directors serves as the chief executive officer of Evolent. The Company exercises significant influence over Evolent, but does not control Evolent and is not the primary beneficiary of Evolent’s activities. The Company’s investment in Evolent is accounted for under the equity method of accounting, with the Company’s proportionate share of the income or loss recognized in the consolidated statements of income. As of December 31, 2012, the Company’s equity interest in Evolent was 31%. The decrease from the initial equity interest is due to the issuance of equity to Evolent employees pursuant to their equity incentive plan, as well as an additional equity investment from certain early customers in July 2012. As a result of this dilution, the Company recognized a $0 and $1.1 million gain on its investment which is included in equity in loss of unconsolidated entity on the accompanying consolidated statements of income for the three and nine months ended December 31, 2012. The Company’s proportionate share of the losses of Evolent during the three and nine months ended December 31, 2012 was $1.9 million and $5.7 million, respectively. Evolent is in the early stages of its business plan and, as a result, the Company expects Evolent to incur losses and require additional funding in the future. The Company’s investment in Evolent will be evaluated for impairment whenever events or changes in circumstances indicate that there may be an other-than-temporary decline in value. The Company believes that no such impairment indicators existed during the nine months ended December 31, 2012.
The following is a summary of the financial position of Evolent, as of the dates presented (in thousands):
As of | ||||||||
December 31, 2012 | March 31, 2012 | |||||||
(unaudited) | ||||||||
Assets: | ||||||||
Cash | $ | 5,252 | $ | 14,807 | ||||
Other current assets | 4,640 | 821 | ||||||
Intangible assets, net | 2,165 | 2,755 | ||||||
Other non-current assets | 4,388 | 1,152 | ||||||
|
|
|
| |||||
Total assets | $ | 16,445 | $ | 19,535 | ||||
|
|
|
| |||||
Liabilities and Members’ Equity: | ||||||||
Deferred revenue | $ | 4,610 | $ | 200 | ||||
Accounts payable and accrued liabilities | 6,254 | 669 | ||||||
Long-term liabilities | 6 | 359 | ||||||
Member’s equity | 5,575 | 18,307 | ||||||
|
|
|
| |||||
Total liabilities and member’s equity | $ | 16,445 | $ | 19,535 | ||||
|
|
|
|
8
Table of Contents
The following is a summary of the operating results of Evolent for the periods presented (in thousands) (unaudited):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Revenue | $ | 5,362 | $ | 535 | $ | 7,624 | $ | 535 | ||||||||
Operating expenses | (11,230 | ) | (1,917 | ) | (23,885 | ) | (1,917 | ) | ||||||||
Depreciation and amortization | (200 | ) | (2 | ) | (682 | ) | (2 | ) | ||||||||
Interest, net | 5 | — | 12 | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net loss | $ | (6,063 | ) | $ | (1,384 | ) | $ | (16,931 | ) | $ | (1,384 | ) | ||||
|
|
|
|
|
|
|
|
Note 6. Other non-current assets
In June 2009, the Company invested in the convertible preferred stock of a private company that provides technology tools and support services to health care providers, including the Company’s members. In addition, the Company entered into a licensing agreement with that company. As part of its investment, the Company received warrants to purchase up to 6,015,000 shares of the company’s common stock at an exercise price of $1.00 per share as certain performance criteria are met. The warrants are exercisable through June 19, 2019. The warrants contain a net settlement feature and therefore are considered to be a derivative financial instrument. A $0.1 million downward adjustment was made to the fair value of the warrants during the nine months ended December 31, 2012. The warrants are recorded at their fair value, which was $340,000 as of December 31, 2012 and $450,000 as of March 31, 2012, and are included in other non-current assets on the accompanying consolidated balance sheets. The change in the fair value of the warrants is recorded in other income, net on the accompanying consolidated statements of income. For additional information regarding the fair value of these warrants, see Note 10, “Fair value measurements.” The convertible preferred stock investment is recorded at cost, and the carrying amount of this investment as of December 31, 2012 of $5.0 million is included in other non-current assets on the accompanying consolidated balance sheets. The convertible preferred stock accrues dividends at an annual rate of 8% that are payable if and when declared by the investee’s board of directors. As of December 31, 2012, no dividends had been declared by the investee or recorded by the Company. This investment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of this asset may not be recoverable. The Company believes that no such impairment indicators existed during the nine months ended December 31, 2012 or 2011.
Note 7. Noncontrolling interests
On July 5, 2012, the Company entered into an agreement with an entity created for the sole purpose of providing consulting services for the Company on an exclusive basis. The Company’s relationship with the entity is governed by a services agreement and other documents that provide the entity’s owners the conditional right to require the Company to purchase their ownership interests (“Put Option”) at any time after certain conditions have been satisfied through December 31, 2014. As of December 31, 2012, these conditions had not been satisfied. These agreements also provide the Company a conditional right to require the entity’s owners to sell their ownership interests to the Company (“Call Option”) at any time between July 5, 2013 and December 31, 2014. The equity interest in this entity is classified as a redeemable noncontrolling interest, which is presented outside of permanent equity as the redemption is not solely within the Company’s control. The redeemable noncontrolling interest is recorded at its initial fair value of $0.1 million and has not been subsequently adjusted, as management’s current judgment is that it is not probable that the Put Option will become exercisable prior to its expiration due to uncertainty in the achievement of certain performance conditions outlined in the agreement. If the Put Option were to become exercisable in the future, the estimated maximum total redemption amount of the redeemable noncontrolling interest under the Put Option would be approximately $7.5 million, which would be recorded as a reduction to net income available to common stockholders.
The Company has determined that this entity meets the definition of a variable interest entity over which it has significant influence and, as a result, has consolidated the results of this entity into its consolidated financial statements. Noncontrolling interests represent the entity’s owners’ claims on consolidated investments where the Company owns less than a 100% interest. As of December 31, 2012, the Company has a 0% ownership interest in this entity. The Company records these interests at their initial fair value, adjusting the basis prospectively for the noncontrolling holders’ share of the respective consolidated investments’ results of operations and applicable changes in ownership.
9
Table of Contents
Note 8. Property and equipment
Property and equipment consists of leasehold improvements, furniture, fixtures, equipment, capitalized internal software development costs, and acquired developed technology. Property and equipment is stated at cost, less accumulated depreciation and amortization. In certain of its membership programs, the Company provides software tools under hosting arrangements where the software application resides on the Company’s or its service providers’ hardware. The members do not take delivery of the software and only receive access to the software tools during the term of their membership agreement. Software development costs that are incurred in the preliminary project stage are expensed as incurred. During the development stage, direct consulting costs and payroll-related costs for employees that are directly associated with each project are capitalized and amortized over the estimated useful life of the software once placed into operation. Capitalized software is amortized using the straight-line method over its estimated useful life, which is generally five years. Replacements and major improvements are capitalized, while maintenance and repairs are charged to expense as incurred.
The acquired developed technology is classified as software within property and equipment because the developed software application resides on the Company’s or its service providers’ hardware. Amortization for acquired developed software is included in depreciation and amortization on the Company’s consolidated statements of income. Developed software obtained through acquisitions is amortized over its weighted average estimated useful life of approximately nine years based on the cash flow estimate used to determine the value of the asset.
Furniture, fixtures, and equipment are depreciated using the straight-line method over the estimated useful lives of the assets, which range from three to seven years. Leasehold improvements are depreciated using the straight-line method over the shorter of the estimated useful lives of the assets or the lease term. There are no capitalized leases included in property and equipment for the periods presented.
The amount of depreciation expense recognized on plant, property, and equipment during the three and nine months ended December 31, 2012 was approximately $3.6 million and $9.8 million, respectively. The amount of depreciation expense recognized on plant, property, and equipment during the three and nine months ended December 31, 2011 was approximately $2.2 million and $6.3 million, respectively.
Internally developed capitalized software is classified as software within property and equipment and has an estimated useful life of five years. As of December 31, 2012 and March 31, 2012, the carrying value of internally developed capitalized software was $26.0 million and $15.0 million, respectively. Property and equipment consists of the following (in thousands):
As of | ||||||||
December 31, 2012 | March 31, 2012 | |||||||
Leasehold improvements | $ | 26,003 | $ | 23,692 | ||||
Furniture, fixtures, and equipment | 34,886 | 26,529 | ||||||
Software | 57,988 | 43,211 | ||||||
|
|
|
| |||||
Property and equipment, gross | 118,877 | 93,432 | ||||||
Accumulated depreciation and amortization | (53,533 | ) | (43,779 | ) | ||||
|
|
|
| |||||
Property and equipment, net | $ | 65,344 | $ | 49,653 | ||||
|
|
|
|
The Company evaluates its long-lived assets for impairment when changes in circumstances exist that suggest the carrying value of a long-lived asset may not be fully recoverable. If an indication of impairment exists, and the Company’s net book value of the related assets is not fully recoverable based upon an analysis of its estimated undiscounted future cash flows, the assets are written down to their estimated fair value. The Company did not recognize any material impairment losses on any of its long-lived assets during the nine months ended December 31, 2012 or 2011.
Note 9. Goodwill and intangibles
Included in the Company’s goodwill and intangibles balances are goodwill and acquired intangibles and internally developed capitalized software for sale. Goodwill is not amortized as it has an estimated infinite life. Goodwill is reviewed for impairment at least annually as of March 31, or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company believes that no such impairment indicators existed during the nine months ended December 31, 2012 or 2011. There was no impairment of goodwill recorded in the nine months ended December 31, 2012 or 2011.
10
Table of Contents
Intangible assets with finite lives are amortized on a straight-line basis over their estimated useful lives, which range from six months to ten years. As of December 31, 2012, the weighted average remaining useful life of acquired intangibles was approximately 5.7 years. As of December 31, 2012, the weighted average remaining useful life of internally developed intangibles was approximately 4.0 years.
The gross and net carrying balances and accumulated amortization of intangibles are as follows (in thousands):
As of December 31, 2012 | As of March 31, 2012 | |||||||||||||||||||||||||||
Weighted average useful life | Gross carrying amount | Accumulated amortization | Net carrying amount | Gross carrying amount | Accumulated amortization | Net carrying amount | ||||||||||||||||||||||
Intangibles | ||||||||||||||||||||||||||||
Internally developed intangible for sale: | ||||||||||||||||||||||||||||
Capitalized software | 5.0 | $ | 5,601 | $ | (826 | ) | $ | 4,775 | $ | 3,048 | $ | (380 | ) | $ | 2,668 | |||||||||||||
Acquired intangibles: | ||||||||||||||||||||||||||||
Developed software | 6.1 | 19,250 | (3,854 | ) | 15,396 | 6,450 | (2,567 | ) | 3,883 | |||||||||||||||||||
Customer relationships | 7.3 | 12,700 | (4,257 | ) | 8,443 | 11,900 | (2,914 | ) | 8,986 | |||||||||||||||||||
Trademarks | 6.3 | 4,200 | (1,978 | ) | 2,222 | 2,700 | (1,625 | ) | 1,075 | |||||||||||||||||||
Non-compete agreements | 4.3 | 1,400 | (566 | ) | 834 | 1,100 | (393 | ) | 707 | |||||||||||||||||||
Customer contracts | 4.9 | 5,199 | (3,516 | ) | 1,683 | 5,199 | (3,134 | ) | 2,065 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||
Total other intangibles | $ | 48,350 | $ | (14,997 | ) | $ | 33,353 | $ | 30,397 | $ | (11,013 | ) | $ | 19,384 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for intangible assets for the three and nine months ended December 31, 2012, recorded in depreciation and amortization on the accompanying consolidated statements of income, was approximately $1.6 million and $4.0 million, respectively. Amortization expense for intangible assets for the three and nine months ended December 31, 2011, recorded in depreciation and amortization on the accompanying consolidated statements of income, was approximately $1.4 million and $3.8 million, respectively. The following approximates the anticipated aggregate amortization expense to be recorded in depreciation and amortization on the consolidated statements of income for the remaining three months of the fiscal year ending March 31, 2013 and for each of the fiscal years ending March 31, 2014 through 2017: $1.8 million; $7.1 million; $6.9 million; $4.1 million; and $3.6 million, respectively; and $7.8 million thereafter.
Note 10. Fair value measurements
Financial assets and liabilities
The estimated fair values of financial instruments are determined based on relevant market information. These estimates involve uncertainty and cannot be determined with precision. The Company’s financial instruments consist primarily of cash, cash equivalents, marketable securities, and common stock warrants. In addition, contingent earn-out liabilities resulting from business combinations are recorded at fair value. The following methods and assumptions are used to estimate the fair value of each class of financial assets or liabilities that are valued on a recurring basis.
Cash and cash equivalents. This includes all cash and liquid investments with an original maturity of three months or less from the date acquired. The carrying amount approximates fair value because of the short maturity of these instruments. Cash equivalents consist of money market funds with original maturity dates of less than three months for which the fair value is based on quoted market prices. The Company’s cash and cash equivalents are held at major commercial banks.
Marketable securities. The Company’s marketable securities, consisting of U.S. government-sponsored enterprise obligations and various state tax-exempt notes and bonds, are classified as available-for-sale and are carried at fair market value based on quoted market prices.
Common stock warrants. The Company holds warrants to purchase common stock in an entity that provides technology tools and support services to health care providers, including the Company’s members, that are exercisable for up to 6,015,000 of the shares of the entity, as certain performance criteria are met. The common stock warrants meet the definition of a derivative and are carried at fair value in other non-current assets on the accompanying consolidated balance sheets. Gains or losses from changes in the fair value of the warrants are recognized in other income, net on the accompanying consolidated statements of income. See Note 6, “Other non-current assets,” for additional information. The fair value of these warrants is determined using a Black-Scholes-Merton model. Key inputs into this methodology are the estimate of underlying value of the common shares of the entity that issued the warrants and the estimate of level of performance criteria that will be achieved. The entity that issued the warrants is private, and the estimate of performance criteria to be met is specific to the Company. These inputs are unobservable and are considered key estimates made by the Company.
11
Table of Contents
Contingent earn-out liabilities. This class of financial liabilities represents the Company’s estimated fair value of the contingent earn-out liabilities related to acquisitions based on probability assessments of certain performance achievements during the earn-out periods. Contingent earn-out liabilities are included in other long-term liabilities on the accompanying consolidated balance sheets. See Note 4, “Acquisitions,” for additional information.
Measurements
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The valuation can be determined using widely accepted valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). As a basis for applying a market-based approach in fair value measurements, GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
• | Level 1—Quoted prices in active markets for identical assets or liabilities. |
• | Level 2—Observable market-based inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. |
• | Level 3—Unobservable inputs that are supported by little or no market activity, such as discounted cash flow methodologies. |
Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no significant transfers between Level 1, Level 2, or Level 3 during the nine months ended December 31, 2012 or 2011.
The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the necessary disclosures are as follows (in thousands):
Fair value as of December 31, | Fair value measurement as of December 31, 2012 using fair value hierarchy | |||||||||||||||
2012 | Level 1 | Level 2 | Level 3 | |||||||||||||
Financial assets | ||||||||||||||||
Cash and cash equivalents (1) | $ | 81,743 | $ | 81,743 | $ | — | $ | — | ||||||||
Available-for-sale marketable securities (2) | 134,772 | 134,772 | — | — | ||||||||||||
Common stock warrants (3) | 340 | — | — | 340 | ||||||||||||
Financial liabilities | ||||||||||||||||
Contingent earn-out liabilities (4) | 14,800 | — | — | 14,800 |
Fair value as of March 31, | Fair value measurement as of March 31, 2012 using fair value hierarchy | |||||||||||||||
2012 | Level 1 | Level 2 | Level 3 | |||||||||||||
Financial assets | ||||||||||||||||
Cash and cash equivalents (1) | $ | 60,642 | $ | 60,642 | $ | — | $ | — | ||||||||
Available-for-sale marketable securities (2) | 127,444 | 127,444 | — | — | ||||||||||||
Common stock warrants (3) | 450 | — | — | 450 | ||||||||||||
Financial liabilities | ||||||||||||||||
Contingent earn-out liabilities (4) | 20,200 | — | — | 20,200 |
(1) | Fair value is based on quoted market prices. |
(2) | Fair value is determined using quoted market prices of the assets. For further detail, see Note 3, “Marketable securities.” |
(3) | The fair value of the common stock warrants as of December 31, 2012 and March 31, 2012 was calculated to be $0.21 per share and $0.24 per share, respectively, using the Black-Scholes-Merton model. The significant assumptions as of December 31, 2012 were as follows: risk-free interest rate of 1.2%; expected term of 6.45 years; expected volatility of 39.92%; dividend yield of 0.0%; weighted average exercise price of $0.69 per share; and a range of warrants to become exercisable of between 1,400,000 and 1,500,000 shares. The significant assumptions as of March 31, 2012 were as follows: risk-free interest rate of 1.1%; expected term of 6.97 years; expected volatility of 41.03%; dividend yield of 0.0%; weighted average exercise price of $0.71 per share; and a range of warrants to become exercisable of between 1,400,000 and 1,800,000 shares. |
(4) | This fair value measurement is based on unobservable inputs that are supported by little or no market activity and reflect the Company’s own assumptions in measuring fair value using the income approach. In developing these estimates, the Company considered certain performance projections, historical results, and general macro-economic environment and industry trends. |
12
Table of Contents
Common stock warrants
The Company’s fair value estimate of the common stock warrants received in connection with its June 2009 investment was zero as of the investment date. Changes in the fair value of the common stock warrants subsequent to the investment date are recognized in earnings in the periods during which the estimated fair value changes. The change in the fair value of the common stock warrants during the nine months ended December 31, 2012 was driven primarily by a slight decrease in the estimated performance targets that will be achieved. The following table represents a reconciliation of the change in the fair value of the common stock warrants for the three and nine months ended December 31, 2012 and 2011 (in thousands):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Beginning balance | $ | 340 | $ | — | $ | 450 | $ | — | ||||||||
Fair value change in common stock warrants (1) | — | — | (110 | ) | — | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Ending balance | $ | 340 | $ | — | $ | 340 | $ | — | ||||||||
|
|
|
|
|
|
|
|
(1) | Amounts were recognized in other income, net on the accompanying consolidated statements of income. |
Contingent earn-out liabilities
The Company entered into an earn-out agreement in connection with its acquisition of Southwind Health Partners, L.L.C. and Southwind Navigator, LLC (together, “Southwind”) on December 31, 2009. The additional contingent payments, which have no guaranteed maximum, become due and payable to the former owner of the Southwind business if certain milestones are met over the evaluation periods beginning at the acquisition date and extending through December 31, 2014. The fair value of the Southwind earn-out liability is impacted by changes in estimates regarding expected operating results, changes in the valuation of the Company’s stock price, and an applied discount rate, which was 15.0% as of December 31, 2012. The Company’s fair value estimate of the Southwind earn-out liability was $5.6 million as of the date of acquisition. On October 31, 2012, the Company transferred 112,408 shares of its common stock to the former owners of Southwind to satisfy the component of the contingent obligation payable in the Company’s common stock, which reduced the related earn-out liability by $5.4 million. As of December 31, 2012, $7.1 million had been earned and paid in cash to the former owners of the Southwind business. As of December 31, 2012, based on current facts and circumstances, the estimated aggregate fair value of the remaining contingent obligation was $9.4 million, which will be paid at various intervals, if earned, over the evaluation periods which extend through December 31, 2014.
The Company entered into an earn-out agreement in connection with its acquisition of substantially all the assets of Cielo MedSolutions, LLC (“Cielo”) on February 1, 2011. The additional contingent payments, which were not to exceed $7.0 million, were to become due and payable to the former owner of the Cielo business if certain product development and subscription milestones were met over the evaluation periods beginning at the acquisition date and extending through 2012. The Company’s fair value estimate of the Cielo earn-out liability, which was payable in cash, was $4.4 million as of the date of acquisition and was increased to $4.7 million during the three months ended December 31, 2012. As of December 31, 2012, $4.7 million was earned and paid to the former owner. The estimated aggregate fair value of the remaining contingent obligation for Cielo as of December 31, 2012 was zero.
The Company’s fair value estimate of the PivotHealth earn-out liability, which is payable in cash, was $2.9 million as of the date of acquisition. The estimated aggregate fair value of the contingent obligation for PivotHealth as of December 31, 2012 was $2.9 million. The fair value of the PivotHealth earn-out liability is impacted by changes in estimates regarding expected operating results and a discount rate, which was 15.0% as of December 31, 2012. See Note 4, “Acquisitions,” for additional information regarding the PivotHealth acquisition and related earn-out liability.
The Company’s fair value estimate of the 360Fresh earn-out liability, which is payable in cash, was $2.5 million as of the date of acquisition. The fair value of the 360Fresh earn-out liability is impacted by changes in estimates regarding expected operating results and a discount rate, which was 20.0% as of December 31, 2012. See Note 4, “Acquisitions,” for additional information regarding the 360Fresh acquisition and related earn-out liability.
13
Table of Contents
Changes in the fair value of the contingent earn-out liabilities subsequent to the acquisition date, including changes arising from events that occurred after the acquisition date, such as changes in the Company’s estimate of performance achievements, discount rates, and stock price, are recognized in earnings in the periods during which the estimated fair value changes. The following table represents a reconciliation of the change in the contingent earn-out liabilities for the three and nine months ended December 31, 2012 and 2011 (in thousands):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Beginning balance | $ | 22,500 | $ | 23,600 | $ | 20,200 | $ | 15,500 | ||||||||
Fair value change in Southwind contingent earn-out liability (1) | 500 | 3,800 | 4,300 | 9,600 | ||||||||||||
Fair value change in Cielo contingent earn-out liability (1) | 300 | — | 400 | (300 | ) | |||||||||||
Fair value change in PivotHealth contingent earn-out liability (1) | 100 | — | (300 | ) | — | |||||||||||
Final adjustment to Concuity contingent earn-out liability (1) | — | (4,000 | ) | — | (4,000 | ) | ||||||||||
Southwind earn-out payment | (9,400 | ) | — | (10,600 | ) | (300 | ) | |||||||||
Cielo earn-out payment | (1,700 | ) | — | (1,700 | ) | — | ||||||||||
Addition of PivotHealth contingent earn-out liability | — | — | — | 2,900 | ||||||||||||
Addition of 360Fresh contingent earn-out liability | 2,500 | — | 2,500 | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Ending balance | $ | 14,800 | $ | 23,400 | $ | 14,800 | $ | 23,400 | ||||||||
|
|
|
|
|
|
|
|
(1) | Amounts were recognized in cost of services on the accompanying consolidated statements of income. |
Non-financial assets and liabilities
Certain assets and liabilities are not measured at fair value on an ongoing basis but instead are measured at fair value on a non-recurring basis; that is, such assets and liabilities are subject to fair value adjustments in certain circumstances (e.g., when there is evidence of impairment). During the nine months ended December 31, 2012 and 2011, no fair value adjustments or material fair value measurements were required for non-financial assets or liabilities.
Note 11. Stock-based compensation
Information with respect to common stock options granted under the Company’s stock incentive plans during the nine months ended December 31, 2012 and 2011 are as follows:
Nine Months Ended December 31, | ||||||||||||||||
2012 | 2011 | |||||||||||||||
Number of Options | Weighted Average Exercise Price | Number of Options | Weighted Average Exercise Price | |||||||||||||
Outstanding, April 1 | 3,812,228 | $ | 17.04 | 5,059,198 | $ | 16.30 | ||||||||||
Granted | 361,844 | 44.00 | 601,412 | 24.97 | ||||||||||||
Exercised | (1,342,510 | ) | 16.08 | (1,329,718 | ) | 17.29 | ||||||||||
Forfeited | (4,500 | ) | 9.26 | (63,872 | ) | 19.67 | ||||||||||
Cancellations | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Outstanding, December 31 | 2,827,062 | $ | 20.96 | 4,267,020 | $ | 17.17 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Exercisable, December 31 | 1,270,458 | $ | 17.61 | |||||||||||||
|
|
|
|
The weighted average fair value of the options granted during the nine months ended December 31, 2012 is estimated at $13.33 per share on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: risk-free interest rate of 0.7%, an expected life of approximately four years, volatility of 37.23%, and dividend yield of 0% over the expected life of the option.
14
Table of Contents
The following table summarizes the changes in restricted stock units (“RSUs”) granted under the Company’s stock incentive plans during the nine months ended December 31, 2012 and 2011:
Nine Months Ended December 31, | ||||||||||||||||
2012 | 2011 | |||||||||||||||
Number of RSUs | Weighted Average Grant Date Fair Value | Number of RSUs | Weighted Average Grant Date Fair Value | |||||||||||||
Non-vested, April 1 | 896,640 | $ | 20.77 | 664,218 | $ | 17.34 | ||||||||||
Granted | 340,756 | 44.34 | 454,084 | 24.46 | ||||||||||||
Forfeited | (2,904 | ) | 22.75 | (1,274 | ) | 18.67 | ||||||||||
Vested | (273,444 | ) | 46.19 | (146,572 | ) | 25.60 | ||||||||||
|
|
|
| |||||||||||||
Non-vested, December 31 | 961,048 | $ | 29.40 | 970,456 | $ | 20.83 | ||||||||||
|
|
|
|
The Company recognized stock-based compensation expense in the following consolidated statements of income line items for stock options and RSUs, for the three and nine months ended December 31, 2012 and 2011 (in thousands, except per share amounts):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Stock-based compensation expense included in: | ||||||||||||||||
Costs and expenses: | ||||||||||||||||
Cost of services | $ | 1,009 | $ | 884 | $ | 3,002 | $ | 2,574 | ||||||||
Member relations and marketing | 656 | 553 | 1,992 | 1,565 | ||||||||||||
General and administrative | 1,806 | 1,510 | 5,388 | 4,323 | ||||||||||||
Depreciation and amortization | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total costs and expenses | 3,471 | 2,947 | 10,382 | 8,462 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from operations | (3,471 | ) | (2,947 | ) | (10,382 | ) | (8,462 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | (2,142 | ) | $ | (1,777 | ) | $ | (6,406 | ) | $ | (5,224 | ) | ||||
|
|
|
|
|
|
|
| |||||||||
Impact on diluted earnings per share | $ | 0.06 | $ | 0.05 | $ | 0.18 | $ | 0.15 | ||||||||
|
|
|
|
|
|
|
|
There are no stock-based compensation costs capitalized as part of the cost of an asset.
As of December 31, 2012, $29.1 million of total unrecognized compensation cost related to outstanding options and non-vested RSUs was expected to be recognized over a weighted average period of 1.5 years.
Note 12. Discontinued operations
On January 20, 2012, the Company sold its OptiLink business to Kronos Incorporated (“Kronos”) for $8.9 million in cash, net of selling costs. The OptiLink business, which was headquartered in a suburb of Portland, Oregon, employed approximately 35 employees who transferred to Kronos. The components of discontinued operations included in the consolidated statements of income consisted of (in thousands):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Revenue | $ | — | $ | 1,585 | $ | — | $ | 4,727 | ||||||||
Costs and expenses: | ||||||||||||||||
Cost of services | — | 1,309 | — | 4,011 | ||||||||||||
Member relations and marketing | — | 48 | — | 176 | ||||||||||||
Depreciation and amortization | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from discontinued operations before provision for income taxes | — | 228 | — | 540 | ||||||||||||
Provision for income taxes | — | (90 | ) | — | (207 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income from discontinued operations, net of provision for income taxes | $ | — | $ | 138 | $ | — | $ | 333 | ||||||||
|
|
|
|
|
|
|
|
15
Table of Contents
Note 13. Revolving credit facility
On July 30, 2012, the Company entered into a $150.0 million five-year senior secured revolving credit facility (the “Credit Facility”) under a credit agreement, dated as of July 30, 2012, with the lenders party thereto from time to time, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents party thereto. The Company incurred financing fees of $0.8 million in relation to this transaction. Under the Credit Facility, up to $150.0 million principal amount of borrowings and other credit extensions may be outstanding at any time, subject to compliance with specified financial ratios and the satisfaction of other customary conditions to borrowing. The maximum principal amount available under the credit agreement may be increased by up to an additional $50.0 million in minimum increments of $10.0 million at the Company’s election upon the satisfaction of specified conditions. The credit agreement contains a sublimit for up to $5.0 million principal amount of swing line loans outstanding at any time and a sublimit for the issuance of up to $10.0 million of letters of credit outstanding at any time. The facility loans may be borrowed, repaid and reborrowed from time to time during the term of the facility and will mature and be payable in full on July 30, 2017. Consequently, the amount outstanding under the Credit Facility at the end of a period may not be reflective of the total amounts outstanding during such period.
Amounts borrowed under the Credit Facility generally will bear interest at an annual rate calculated, at the Company’s option, on the basis of either (a) an alternate base rate plus the applicable margin for alternate base rate loans under the credit agreement, which ranges from 0.75% to 1.50% based on the Company’s total leverage ratio, or (b) an adjusted LIBO rate plus the applicable margin for eurocurrency loans under the credit agreement, which ranges from 1.75% to 2.50% based on the Company’s total leverage ratio. The Company is required to pay a commitment fee on the unutilized portion of the facility at an annual rate of between 0.25% and 0.40% based on the Company’s total leverage ratio.
As of December 31, 2012, there were no amounts outstanding under the Credit Facility and $150.0 million was available for borrowing.
Note 14. Earnings per share
Basic earnings per share is computed by dividing net income attributable to common stockholders by the number of weighted average common shares outstanding during the period. Diluted earnings per share is computed by dividing net income attributable to common stockholders by the number of weighted average common shares increased by the dilutive effects of potential common shares outstanding during the period. The number of potential common shares outstanding is determined in accordance with the treasury stock method, using the Company’s prevailing tax rates. Certain potential common share equivalents were not included in the computation because their effect was anti-dilutive. Fully diluted shares outstanding for the three and nine months ended December 31, 2012 and the three and nine months ended December 31, 2011 includes contingently issuable shares related to the component of the Southwind earn-out settled in stock. For additional information regarding these shares, see Note 10, “Fair value measurements.”
A reconciliation of basic to diluted weighted average common shares outstanding is as follows (in thousands):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Basic weighted average common shares outstanding | 34,949 | 32,952 | 34,597 | 32,596 | ||||||||||||
Effect of dilutive outstanding stock-based awards | 1,399 | 1,876 | 1,547 | 1,662 | ||||||||||||
Dilutive impact of earn-out liability | 37 | 110 | 87 | 110 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted weighted average common shares outstanding | 36,385 | 34,938 | 36,231 | 34,368 | ||||||||||||
|
|
|
|
|
|
|
|
In the three months ended December 31, 2012 and 2011, 0.4 million and 86,000 shares, respectively, related to share-based compensation awards have been excluded from the calculation of the effect of dilutive outstanding stock-based awards shown above because their effect was anti-dilutive. In the nine months ended December 31, 2012 and 2011, 0.4 million and 0.4 million shares, respectively, related to share-based compensation awards have been excluded from the calculation of the effect of dilutive outstanding stock-based awards shown above because their effect was anti-dilutive.
Note 15. Income taxes
The Company uses a more-likely-than-not recognition threshold based on the technical merits of the tax position taken for the financial statement recognition and measurement of a tax position. If a tax position does not meet the more-likely-than-not initial recognition threshold, no benefit is recorded in the financial statements. The Company does not currently anticipate that the total
16
Table of Contents
amounts of unrecognized tax benefits will significantly change within the next 12 months. The Company classifies interest and penalties on any unrecognized tax benefits as a component of the provision for income taxes. No interest or penalties were recognized in the consolidated statements of income for the three or nine months ended December 31, 2012 or 2011. The Company files income tax returns in U.S. federal and state and foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state, and local tax examinations for filings in major tax jurisdictions before 2008.
Note 16. Stockholders’ equity
During the three and nine months ended December 31, 2012, the Company repurchased 109,654 and 286,881 shares, respectively, of its common stock at a total cost of approximately $5.0 million and $13.0 million, respectively, pursuant to its share repurchase program. During the three and nine months ended December 31, 2011, the Company repurchased 56,158 and 223,438 shares, respectively, of its common stock at a total cost of approximately $1.9 million and $6.6 million, respectively, pursuant to its share repurchase program. The total amount of common stock purchased from inception under the program as of December 31, 2012 was 15,551,661 shares at a total cost of $335.9 million. All repurchases to date have been made in the open market and have been retired as of December 31, 2012. No minimum number of shares subject to repurchase has been fixed and the share repurchase authorization has no expiration date. The Company has funded, and expects to continue to fund, its share repurchases with cash on hand, proceeds from the sale of marketable securities, and cash generated from operations. As of December 31, 2012, the remaining authorized repurchase amount was $14.1 million.
During the nine months ended December 31, 2012, the Company retired 13,551,661 shares of its treasury stock. Upon retirement, these shares resumed the status of authorized but unissued stock. The treasury stock retirement resulted in reductions to common stock of $69,000, treasury stock of $302.8 million, and retained earnings of $302.7 million. A total of 15,551,661 shares of treasury stock have been retired to date. There was no effect on the total stockholders’ equity position as a result of the retirement.
On May 1, 2012, the Company’s Board of Directors approved a two-for-one split of the Company’s common stock to be effected in the form of a stock dividend. As a result of this action, one additional share was issued on June 18, 2012 for each share held by stockholders of record at the close of business on May 31, 2012. The stock split did not have an impact on the Company’s consolidated financial position or results of operations. Share and per share amounts presented in the accompanying consolidated financial statements for dates before June 18, 2012 have been restated to reflect the impact of the stock split.
Note 17. Subsequent events
On January 7, 2013, the Company purchased a convertible term note from Evolent in the aggregate principal amount of approximately $3.5 million. The note bears interest at a rate of 8% per year, with such interest accruing on a daily basis and compounded annually. All outstanding principal and interest is due from Evolent on or before July 7, 2014 unless converted into equity securities of Evolent prior to such date.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Unless the context indicates otherwise, references in this report to the “Company,” the “registrant,” “we,” “our,” and “us” mean The Advisory Board Company and its subsidiaries.
Our fiscal year ends on March 31. Fiscal 2013 is our fiscal year ending on March 31, 2013.
On June 18, 2012, the Company completed a two-for-one split of its outstanding shares of common stock in the form of a stock dividend. Each stockholder of record received one additional share of common stock for each share of common stock owned at the close of business on May 31, 2012. Share numbers and per share amounts presented below for dates before June 18, 2012 have been restated to reflect the impact of the stock split.
This management’s discussion and analysis of financial condition and results of operations includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the “Exchange Act.” Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. These statements can sometimes be identified by our use of forward-looking words such as “may,” “will,” “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates,” or “intends” and similar expressions. These statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the results, performance, or achievements expressed or implied by the forward-looking statements, including the factors discussed under “Item 1A. Risk Factors” in our annual report on Form 10-K for the fiscal year ended March 31, 2012, or the “2012 Form 10-K,” filed with the Securities and Exchange Commission, or “SEC,” and in our subsequent SEC reports. We undertake no obligation to update any forward-looking statements, whether as a result of circumstances or events that arise after the date the statements are made, new information, or otherwise.
17
Table of Contents
Executive Overview
We provide best practices research and analysis, business intelligence and software tools, and management and advisory services through discrete programs to approximately 3,700 organizations, including hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, colleges, universities, and other educational institutions. Members of each program typically are charged a fixed fee and have access to an integrated set of services that may include best practice research studies, executive education seminars, customized research briefs, web-based access to the program’s content database, and software tools.
Our three key areas of focus for fiscal 2013 are to continue to deliver world-class programs that drive significant returns for our members and ensure member loyalty through outstanding value delivery; to make select investments to capture the unique opportunities presented by current health care market conditions, through developing and launching new programs and acquiring products, services, and technologies that improve performance of our members; and to attract, develop, engage, and retain world-class talent across our organization. Success in all of these areas requires very strong execution across our business, and we have an intense focus on setting up each team to manage against and attain high goals in each area of our operations.
Our membership business model allows us to create value for our members by providing proven solutions to common and complex problems as well as quality content on a broad set of relevant issues. Our growth has been driven by strong renewal rates, ongoing addition of new memberships in our existing programs, continued new program launches, acquisition activity, and continued annual price increases. We believe high renewal rates are a reflection of our members’ recognition of the value they derive from participating in our programs. Our revenue grew 22.7% in the nine months ended December 31, 2012 over the prior year period. Our contract value increased 18.2% to $450.0 million as of December 31, 2012 from $380.7 million as of December 31, 2011. We define contract value as the aggregate annualized revenue attributed to all agreements in effect at a particular date, without regard to the initial term or remaining duration of any such agreement.
Our operating costs and expenses consist of cost of services, member relations and marketing, general and administrative expenses, and depreciation and amortization expenses. Cost of services includes the costs associated with the production and delivery of our products and services, consisting of compensation for research personnel, in-house faculty, software developers, and consultants; the organization and delivery of membership meetings, teleconferences, and other events; production of published materials; technology license fees; and costs of developing and supporting our web-based content and software tools. Member relations and marketing includes the costs of acquiring new members and the costs of account management, consisting of compensation, including sales incentives; travel and entertainment expenses; training of personnel; sales and marketing materials; and associated support services. General and administrative expenses include the costs of human resources and recruiting; finance and accounting; management information systems; facilities management; new program development; and other administrative functions. Depreciation and amortization expense includes the cost of depreciation of our property and equipment; amortization of costs associated with the development of software and tools that are offered as part of certain of our membership programs; and amortization of acquired developed technology. Included in our operating costs for each period presented are stock-based compensation expenses and expenses representing additional payroll taxes for compensation expense as a result of the taxable income employees recognized upon the exercise of common stock options and the vesting of restricted stock units.
Critical Accounting Policies
Our accounting policies, which are in compliance with U.S. generally accepted accounting principles, or “GAAP,” require us to apply methodologies, estimates, and judgments that have a significant impact on the results we report in our financial statements. In our 2012 Form 10-K, we have discussed those material accounting policies that we believe are critical and require the use of complex judgment in their application. There have been no material changes to our policies since our fiscal year ended March 31, 2012.
Non-GAAP Financial Presentation
This management’s discussion and analysis presents supplemental measures of our performance which are derived from our consolidated financial information but which are not presented in our consolidated financial statements prepared in accordance with GAAP. These financial measures, which are considered “non-GAAP financial measures” under SEC rules, are referred to as adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share. See “Non-GAAP Financial Measures” below for definitions of such non-GAAP financial measures and reconciliations of each non-GAAP financial measure to the most directly comparable GAAP financial measure.
18
Table of Contents
Results of Operations
The following table shows statements of income data expressed as a percentage of revenue for the periods indicated:
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Revenue | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
Costs and expenses: | ||||||||||||||||
Cost of services, excluding depreciation and amortization | 54.3 | % | 52.3 | % | 53.9 | % | 53.5 | % | ||||||||
Member relations and marketing | 18.8 | % | 18.7 | % | 18.9 | % | 20.3 | % | ||||||||
General and administrative | 14.3 | % | 12.6 | % | 13.8 | % | 13.0 | % | ||||||||
Depreciation and amortization | 4.4 | % | 3.7 | % | 4.1 | % | 3.8 | % | ||||||||
|
|
|
|
|
|
|
| |||||||||
Total costs and expenses | 91.8 | % | 87.3 | % | 90.7 | % | 90.6 | % | ||||||||
|
|
|
|
|
|
|
| |||||||||
Operating income | 8.2 | % | 12.7 | % | 9.3 | % | 9.4 | % | ||||||||
Other income, net | 0.6 | % | 1.7 | % | 0.6 | % | 1.1 | % | ||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations before provision for income taxes and equity in loss of unconsolidated entity | 8.8 | % | 14.4 | % | 9.9 | % | 10.5 | % | ||||||||
Provision for income taxes | (3.4 | %) | (5.7 | %) | (3.7 | %) | (4.1 | %) | ||||||||
Equity in loss of unconsolidated entity | (1.6 | %) | (0.6 | %) | (1.4 | %) | (0.2 | %) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income from continuing operations | 3.8 | % | 8.1 | % | 4.8 | % | 6.2 | % | ||||||||
Discontinued operations: | ||||||||||||||||
Net income from discontinued operations | — | 0.1 | % | — | 0.1 | % | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income before allocation to noncontrolling interest | 3.8 | % | 8.2 | % | 4.8 | % | 6.3 | % | ||||||||
Net loss attributable to noncontrolling interest | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income attributable to common stockholders | 3.8 | % | 8.2 | % | 4.8 | % | 6.3 | % | ||||||||
|
|
|
|
|
|
|
|
Three and nine months ended December 31, 2012 compared to the three and nine months ended December 31, 2011
Overview. Net income attributable to common stockholders decreased to $4.4 million in the three months ended December 31, 2012 from $8.1 million in the three months ended December 31, 2011. The decrease in net income was primarily attributable to increases of $11.6 million in cost of services incurred for new and growing programs, including our 2011 acquisition of PivotHealth, LLC, or “PivotHealth,” as well as our 2012 acquisitions of ActiveStrategy, Inc., or “ActiveStrategy,” and 360Fresh, Inc., or “360Fresh,” increases of $3.4 million in marketing and member relations due to an increase in sales teams to 175, and increases of $4.2 million in general and administrative expenses related to increases in finance, information technology, and human resources expense incurred to support our growing employee base. Also attributing to the decrease in net income was an increase of $1.5 million in depreciation and amortization, an increase in our loss from our investment in Evolent Health, Inc., or “Evolent,” during the quarter of $1.3 million, and a $1.1 million gain on our investment in common stock warrants incurred during the three months ended December 31, 2011, the effect of which was partially offset by a 18.1% increase in revenue during the three months ended December 31, 2012. Net income decreased to $15.8 million in the nine months ended December 31, 2012 from $17.1 million in the nine months ended December 31, 2011. The decrease in net income was primarily attributable to increases of $34.1 million in cost of services incurred for new and growing programs, including our 2011 acquisition of PivotHealth, increases of $7.6 million in marketing and member relations due to an increase in sales teams to 175, and increases of $10.6 million in general and administrative expenses related to increases in finance, information technology, and human resources expense incurred to support our growing employee base and increased legal and external advisory spending related to our new credit facility and acquisition activity. Also attributing to the decrease in net income was an increase of $3.6 million in depreciation and amortization, an increase in our loss from our investment in Evolent during the quarter of $4.0 million, and a $1.1 million gain on our investment in common stock warrants incurred during the nine months ended December 31, 2011, the effect of which was partially offset by a 22.7% increase in revenue during the three months ended December 31, 2012.
Adjusted Net Income and Adjusted EBITDA.Adjusted net income was $10.2 million in the three months ended December 31, 2012 compared to $10.5 million in the three months ended December 31, 2011, and adjusted EBITDA increased to $19.3 million in the three months ended December 31, 2012 from $18.9 million in the three months ended December 31, 2011. Adjusted net income increased 15.3% to $32.7 million in the nine months ended December 31, 2012 from $28.3 million in the nine months ended December 31, 2011, and adjusted EBITDA increased 20.5% to $60.2 million in the nine months ended December 31, 2012 from $50.0 million in the nine months ended December 31, 2011. The increases in adjusted net income and adjusted EBITDA were due to increased revenue, the effect of which was partially offset by the costs of new and growing programs, increased investment in our general and administrative infrastructure to support our growing employee base, and an increase in the number of new sales teams.
19
Table of Contents
Revenue.Total revenue increased 18.1% to $116.2 million in the three months ended December 31, 2012 from $98.5 million in the three months ended December 31, 2011, while contract value increased 18.2% to $450.0 million as of December 31, 2012 from $380.7 million as of December 31, 2011. Total revenue increased 22.7% to $331.1 million in the nine months ended December 31, 2012 from $269.9 million in the nine months ended December 31, 2011. The increases in revenue and contract value were primarily attributable to the introduction and expansion of new programs, including our August 1, 2011 acquisition of PivotHealth and our October 1, 2012 acquisition of ActiveStrategy, our cross-selling of existing programs to existing members, and, to a lesser degree, price increases. We offered 56 membership programs as of December 31, 2012 and 52 membership programs as of December 31, 2011.
Cost of services.Cost of services increased to $63.1 million in the three months ended December 31, 2012 from $51.5 million in the three months ended December 31, 2011. Cost of services increased to $178.5 million in the nine months ended December 31, 2012 from $144.4 million in the nine months ended December 31, 2011. The increases in cost of services for the three and nine months ended December 31, 2012 were primarily due to growth and expansion of our Crimson and Southwind programs, including our 2011 acquisition of PivotHealth, as well as our 2012 acquisitions of ActiveStrategy and 360Fresh. Also affecting cost of services were costs associated with the delivery of program content and tools to our expanded membership base, including increased staffing, licensing fees, and other costs. As a percentage of revenue, cost of services was 54.3% and 52.3% for the three months ended December 31, 2012 and 2011, respectively, and 53.9% and 53.5% for the nine months ended December 31, 2012 and 2011, respectively. As a percentage of revenue, cost of services increased in the three months ended December 31, 2012 partially due to an increase in fair value adjustments to our acquisition-related earn-out liabilities. Cost of services includes fair value adjustments to our acquisition-related earn-out liabilities of $0.9 million in the three months ended December 31, 2012 and ($0.2) million the three months ended December 31, 2011, respectively.
Member relations and marketing.Member relations and marketing expense increased 18.6% to $21.8 million in the three months ended December 31, 2012 from $18.4 million in the three months ended December 31, 2011. As a percentage of revenue, member relations and marketing expense in the three months ended December 31, 2012 and 2011 was 18.8% and 18.7%, respectively. Member relations and marketing expense increased 14.0% to $62.4 million in the nine months ended December 31, 2012 from $54.8 million in the nine months ended December 31, 2011. As a percentage of revenue, member relations and marketing expense in the nine months ended December 31, 2012 and 2011 was 18.9% and 20.3%, respectively. The increases in member relations and marketing expense were primarily attributable to an increase in sales staff and related travel and other associated costs, as well as to an increase in member relations personnel and related costs required to serve our expanding membership base. During the three months ended December 31, 2012 and 2011, we had an average of 175 and 146 new business development teams, respectively.
General and administrative.General and administrative expense increased to $16.6 million in the three months ended December 31, 2012 from $12.4 million in the three months ended December 31, 2011. As a percentage of revenue, general and administrative expense increased to 14.3% in the three months ended December 31, 2012 from 12.6% in the three months ended December 31, 2011. General and administrative expense increased to $45.7 million in the nine months ended December 31, 2012 from $35.1 million in the nine months ended December 31, 2011. As a percentage of revenue, general and administrative expense increased to 13.8% in the nine months ended December 31, 2012 from 13.0% in the nine months ended December 31, 2011. The increases in general and administrative costs for the three and nine months ended December 31, 2012 were primarily attributable to increased costs incurred to improve our finance, human resources, information technology, and facility operations infrastructure to support our growing employee base and number of office locations, increased legal and external advisory spending related to our new credit facility and acquisition activity, and an increase in share-based compensation expense.
Depreciation and amortization.Depreciation and amortization expense increased to $5.2 million, or 4.4% of revenue, in the three months ended December 31, 2012, from $3.7 million, or 3.7% of revenue, in the three months ended December 31, 2011. Depreciation and amortization expense increased to $13.7 million, or 4.1% of revenue, in the nine months ended December 31, 2012, from $10.1 million, or 3.7% of revenue, in the nine months ended December 31, 2011. The increases in depreciation and amortization were primarily due to increased amortization expense from developed capitalized internal-use software tools, our 2011 acquisition of PivotHealth and our 2012 acquisitions of 360Fresh and ActiveStrategy, and to a lesser extent, addition of leased space in our Austin, TX office and Washington, D.C. headquarters.
Other income, net.Other income, net decreased to $0.7 million in the three months ended December 31, 2012 from $1.6 million in the three months ended December 31, 2011. Other income, net consists of interest income, interest expense, foreign currency losses and gains, and gains and losses on investment in common stock warrants. Higher average cash and investment balances contributed to an increase in interest income to $0.9 million in the three months ended December 31, 2012 from $0.6 million in the three months ended December 31, 2011. We recognized foreign exchange losses of $63,000 and $72,000 during the three months ended December 31, 2012 and 2011, respectively, as a result of the effect of fluctuating currency rates on our receivable balances denominated in foreign currencies. During the three months ended December 31, 2011, we recognized a $1.1 million gain on our investment in common stock warrants. During the three months ended December 31, 2012, we recognized $0.1 million in revolver fees. Other income, net decreased to $2.0 million in the nine months ended December 31, 2012 from $2.9 million in the nine months
20
Table of Contents
ended December 31, 2011. Higher average cash and investment balances contributed to an increase in interest income to $2.6 million in the nine months ended December 31, 2012 from $1.7 million in the nine months ended December 31, 2011. We recognized foreign exchange losses of $0.3 million and foreign exchange gains of $0.1 million during the nine months ended December 31, 2012 and 2011, respectively, as a result of the effect of fluctuating currency rates on our receivable balances denominated in foreign currencies. During the nine months ended December 31, 2012 and 2011, we recognized a $0.1 million loss and $1.1 million gain, respectively, on our investment in common stock warrants. During the nine months ended December 31, 2012, we recognized $0.2 million in revolver fees.
Provision for income taxes.Our provision for income taxes was $3.9 million and $5.6 million in the three months ended December 31, 2012 and 2011, respectively. Our provision for income taxes was $12.6 million and $10.9 million in the nine months ended December 31, 2012 and 2011, respectively. Our effective tax rate in the three and nine months ended December 31, 2012 was 38.3% compared to 39.7% in the three months ended December 31, 2011, and 38.6% in the nine months ended December 31, 2011. The decrease in our effective tax rate for the three and nine months ended December 31, 2012 was primarily due to a higher balance of tax-exempt investments and an increase in Washington, D.C. tax credits that we receive under the New E-conomy Transformation Act of 2000, partially offset by a slight increase in our effective state tax rate due to changes in apportionment.
Equity in loss of unconsolidated entity. Our proportionate share of the losses of Evolent during the three months ended December 31, 2012 and 2011 were $1.9 million and $0.1 million, respectively, and for the nine months ended December 31, 2012 and 2011 were $5.7 million and $0.1 million, respectively. Evolent was established in August 2011 and continues to be in the early stages of its business plan. As a result, we expect Evolent to incur losses and require additional funding in the future. The losses recognized during the three and nine months ended December 31, 2012 were partially offset by a $1.1 million gain on investment recognized in connection with the dilution of our ownership percentage resulting from the issuance of equity to Evolent employees pursuant to their equity incentive plan, as well as an additional equity investment from certain early customers in July 2012.
Income from discontinued operations, net of tax.On January 20, 2012, we sold substantially all of the assets of our OptiLink business. As a result, the net income generated by OptiLink in the three and nine months ended December 31, 2011 has been presented as discontinued operations.
Stock-based compensation expense.We recognized the following stock-based compensation expense in the consolidated statements of income line items for stock options and restricted stock units or “RSUs” issued under our stock incentive plans for the three and nine months ended December 31, 2012 (in thousands, except per share amounts):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Stock-based compensation expense included in: | ||||||||||||||||
Costs and expenses: | ||||||||||||||||
Cost of services | $ | 1,009 | $ | 884 | $ | 3,002 | $ | 2,574 | ||||||||
Member relations and marketing | 656 | 553 | 1,992 | 1,565 | ||||||||||||
General and administrative | 1,806 | 1,510 | 5,388 | 4,323 | ||||||||||||
Depreciation and amortization | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total costs and expenses | 3,471 | 2,947 | 10,382 | 8,462 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from operations | (3,471 | ) | (2,947 | ) | (10,382 | ) | (8,462 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | (2,142 | ) | $ | (1,777 | ) | $ | (6,406 | ) | $ | (5,224 | ) | ||||
|
|
|
|
|
|
|
| |||||||||
Impact on diluted earnings per share | $ | 0.06 | $ | 0.05 | $ | 0.18 | $ | 0.15 | ||||||||
|
|
|
|
|
|
|
|
There are no stock-based compensation costs capitalized as part of the cost of an asset.
As of December 31, 2012, $29.1 million of total unrecognized compensation cost related to outstanding options and non-vested RSUs was expected to be recognized over a weighted average period of 1.5 years.
Non-GAAP Financial Measures
The tables below present information for the periods indicated about our adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share. We define “adjusted EBITDA” as net income attributable to common stockholders before provision for income taxes from continuing operations; other income, net, which includes interest income and expense, gains and losses on investment in common stock warrants, and foreign currency losses and gains; depreciation and amortization; equity in loss of unconsolidated entity and related gains or losses associated with the underlying investments; discontinued operations, net of tax; acquisition and similar transaction charges; fair value adjustments to acquisition-related earn-out liabilities; and share-based compensation expense. We define “adjusted net income” as net income attributable to common stockholders excluding, net of tax
21
Table of Contents
effect, equity in loss of unconsolidated entity and related gains or losses associated with the underlying investments; discontinued operations; gains and losses on investment in common stock warrants; amortization of acquisition-related intangibles; acquisition and similar transaction charges; fair value adjustments to acquisition-related earn-out liabilities; and share-based compensation expense. We define “non-GAAP earnings per diluted share” as earnings per diluted share excluding, net of tax effect, equity in loss of unconsolidated entity and related gains or losses associated with the underlying investments; discontinued operations; gains and losses on investment in common stock warrants; amortization of acquisition-related intangibles; acquisition and similar transaction charges; fair value adjustments to acquisition-related earn-out liabilities; and share-based compensation expense. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Presentation” in our 2012 Form 10-K for our reasons for including these financial measures in this report and for a description of material limitations with respect to the usefulness of such measures. A reconciliation of adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share to the most directly comparable GAAP financial measures is provided below (in thousands, except per share data).
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Net income attributable to common stockholders | $ | 4,442 | $ | 8,052 | $ | 15,764 | $ | 17,126 | ||||||||
Equity in loss of unconsolidated entity | 1,870 | 609 | 4,586 | 609 | ||||||||||||
Provision for income taxes from continuing operations | 3,918 | 5,612 | 12,565 | 10,939 | ||||||||||||
Discontinued operations, net of tax | — | (138 | ) | — | (333 | ) | ||||||||||
Other income, net | (738 | ) | (1,625 | ) | (2,002 | ) | (2,870 | ) | ||||||||
Depreciation and amortization | 5,223 | 3,662 | 13,739 | 10,112 | ||||||||||||
Acquisition and similar transaction charges | 252 | — | 851 | 648 | ||||||||||||
Fair value adjustments to acquisition-related earn-out liabilities | 859 | (200 | ) | 4,359 | 5,300 | |||||||||||
Share-based compensation expense | 3,471 | 2,947 | 10,382 | 8,462 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Adjusted EBITDA | $ | 19,297 | $ | 18,919 | $ | 60,244 | $ | 49,993 | ||||||||
|
|
|
|
|
|
|
|
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Net income attributable to common stockholders | $ | 4,442 | $ | 8,052 | $ | 15,764 | $ | 17,126 | ||||||||
Equity in loss of unconsolidated entity | 1,870 | 609 | 4,586 | 609 | ||||||||||||
Discontinued operations, net of tax | — | (138 | ) | — | (333 | ) | ||||||||||
Amortization of acquisition-related intangibles, net of tax | 1,030 | 946 | 2,611 | 2,644 | ||||||||||||
Acquisition and similar transaction charges, net of tax | 155 | — | 525 | 405 | ||||||||||||
Fair value adjustments to acquisition-related earn-out liabilities, net of tax | 530 | (121 | ) | 2,690 | 3,317 | |||||||||||
Gain/loss on investment in common stock warrants, net of tax | — | (663 | ) | 68 | (663 | ) | ||||||||||
Share-based compensation, net of tax | 2,142 | 1,777 | 6,406 | 5,224 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Adjusted net income | $ | 10,169 | $ | 10,462 | $ | 32,650 | $ | 28,329 | ||||||||
|
|
|
|
|
|
|
|
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
GAAP earnings per diluted share | $ | 0.12 | $ | 0.23 | $ | 0.44 | $ | 0.50 | ||||||||
Equity in loss of unconsolidated entity | 0.05 | 0.02 | 0.13 | 0.02 | ||||||||||||
Discontinued operations, net of tax | — | — | — | (0.01 | ) | |||||||||||
Amortization of acquisition-related intangibles, net of tax | 0.03 | 0.03 | 0.07 | 0.08 | ||||||||||||
Acquisition and similar transaction charges, net of tax | 0.01 | — | 0.01 | 0.01 | ||||||||||||
Fair value adjustments to acquisition-related earn-out liabilities, net of tax | 0.01 | (0.01 | ) | 0.08 | 0.10 | |||||||||||
Gain/loss on investment in common stock warrants, net of tax | — | (0.02 | ) | — | (0.02 | ) | ||||||||||
Share-based compensation, net of tax | 0.06 | 0.05 | 0.18 | 0.15 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Non-GAAP earnings per diluted share | $ | 0.28 | $ | 0.30 | $ | 0.91 | $ | 0.83 | ||||||||
|
|
|
|
|
|
|
|
Liquidity and Capital Resources
Cash flows generated from operating activities are our primary source of liquidity. We believe that existing cash, cash equivalents, marketable securities balances and operating cash flows will be sufficient to support operating and capital expenditures, as well as share repurchases, during at least the next 12 months. We had cash, cash equivalents, and marketable securities balances of
22
Table of Contents
$216.5 million and $188.1 million as of December 31, 2012 and March 31, 2012, respectively. We expended $13.0 million and $6.6 million in cash to purchase shares of our common stock through our share repurchase program during the nine months ended December 31, 2012 and 2011, respectively. We have no long-term indebtedness.
Cash flows from operating activities.The combination of revenue growth, profitable operations, and payment for memberships in advance of accrual revenue typically results in operating activities that generate cash flows in excess of net income on an annual basis. Cash flows from operating activities fluctuate from quarter to quarter based on the timing of new and renewal contracts as well as certain expenses. Net cash flows provided by operating activities were $73.1 million in the nine months ended December 31, 2012, compared to net cash flows provided by operating activities of $67.2 million in the nine months ended December 31, 2011. The increase in net cash flows provided by operating activities during the current period was primarily due to an increase in adjusted net income, netted by certain acquisition related earn-out payments classified as cash flows used in operating activities.
Cash flows from investing activities.Our cash management and investment strategy and capital expenditure programs affect investing cash flows. Net cash flows used in investing activities were $67.5 million and $67.2 million in the nine months ended December 31, 2012 and 2011, respectively. Investing activities during the nine months ended December 31, 2012 consisted of the acquisitions of 360Fresh and ActiveStrategy for $31.9 million, capital expenditures of $27.9 million, and net purchases of marketable securities of $7.7 million. Investing activities during the nine months ended December 31, 2011 consisted of $16.8 million used in our acquisition of PivotHealth, our initial capital contribution of $10.0 million to Evolent, capital expenditures of $24.7 million, and the net purchases of marketable securities of $15.7 million.
Cash flows from financing activities.We had net cash flows provided by financing activities of $15.5 million and $18.1 million in the nine months ended December 31, 2012 and 2011, respectively. Financing activities during the nine months ended December 31, 2012 primarily consisted of $21.6 million from the issuance of common stock upon the exercise of stock options and $11.8 million in additional tax benefits related to share-based compensation arrangements, offset in part by the repurchase of shares under our repurchase program, withholding of shares to satisfy minimum employee tax withholding for vested restricted stock units, and certain acquisition related earn-out payments classified as cash flows used in financing activities. Financing activities during the nine months ended December 31, 2011 primarily consisted of $23.0 million from the issuance of common stock upon the exercise of stock options, offset in part by share repurchase activity. We repurchased 286,881 shares at a total cost of approximately $13.0 million and 223,438 shares at a total cost of approximately $6.6 million in the nine months ended December 31, 2012 and 2011, respectively, pursuant to our share repurchase program. In the nine months ended December 31, 2012 and 2011, we withheld $3.8 million and $1.3 million in shares, respectively, to satisfy the minimum employee tax withholding for certain vested restricted stock units.
Revolving credit facility. On July 30, 2012, we obtained a $150.0 million five-year senior secured revolving credit facility under a credit agreement, dated as of July 30, 2012, with the lenders party thereto from time to time, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents party thereto.
Under the revolving credit facility, up to $150.0 million principal amount of borrowings and other credit extensions may be outstanding at any time. The facility loans may be borrowed, repaid and reborrowed from time to time during the term of the facility and will mature and be payable in full on July 30, 2017. At our election, and upon our satisfaction of specified conditions, the maximum principal amount available under the credit agreement may be increased by up to an additional $50.0 million in minimum increments of $10.0 million, which may be made available by increasing the revolving loan commitments or by our entry into one or more tranches of term loans. The credit agreement contains a sublimit for up to $5.0 million principal amount of swing line loans outstanding at any time and a sublimit for the issuance of up to $10.0 million of letters of credit outstanding at any time.
The revolving credit facility was undrawn at the facility closing date of July 30, 2012. As of the date of this report, there were no amounts outstanding under the credit facility and $150.0 million was available for borrowing thereunder. We may use the proceeds of borrowings under the facility, when drawn, to finance working capital needs and for general corporate purposes, including permitted acquisitions.
Amounts drawn under the revolving credit facility generally will bear interest at an annual rate calculated, at our option, on the basis of either (a) an alternate base rate plus the applicable margin for alternate base rate loans under the credit agreement, which ranges from 0.75% to 1.50% based on our total leverage ratio, or (b) an adjusted LIBO rate plus the applicable margin for eurocurrency loans under the credit agreement, which ranges from 1.75% to 2.50% based on our total leverage ratio. We are required to pay a commitment fee on the unutilized portion of the facility at an annual rate of between 0.25% and 0.40% based on our total leverage ratio. The interest rate on the alternate base rate loans will fluctuate as the base rate fluctuates, while the interest rate on the eurocurrency loans will be adjusted at the end of each applicable interest period. At the facility closing date, the applicable margin for alternate base rate loans was 0.75% and the applicable margin for eurocurrency loans was 1.75%. Interest on alternate base rate loans will be payable quarterly in arrears, while interest on eurocurrency loans will be payable at the end of each applicable interest period, which may be one, two, three or nine months, except that, in the case of a six-month interest period, interest will be payable at the end of each three-month period.
23
Table of Contents
The Advisory Board Company is the borrower under the revolving credit facility. All of The Advisory Board Company’s obligations under the facility are and will be guaranteed by certain of our existing and future domestic subsidiaries. Our obligations and the obligations of each subsidiary guarantor under the facility are and will be secured by first-priority liens on, and first-priority security interests in, substantially all of our assets, including a pledge of some or all of the capital stock of each of our domestic subsidiaries held by such loan party.
The revolving credit facility contains customary negative covenants restricting certain actions that may be taken by us and our subsidiaries. Subject to specified exceptions, these covenants limit our ability and the ability of our subsidiaries to incur indebtedness, create liens on their assets, pay cash dividends, repurchase our common stock and make other restricted payments, make investments or loans to other parties, sell assets, engage in mergers and acquisitions, enter into transactions with affiliates, and change their business. The facility also contains customary affirmative covenants, including, among others, covenants requiring compliance with laws, maintenance of corporate existence, licenses, properties and insurance, payment of taxes and performance of other material obligations, and delivery of financial and other information to the lenders under the credit agreement.
We are required under the credit agreement to satisfy the following three financial ratios, each of which will be measured for us and our subsidiaries on a consolidated basis as of the end of each fiscal quarter for the period beginning with the quarter ended December 31, 2012 and ending after four consecutive fiscal quarters the end of each such fiscal quarter:
• | a maximum total leverage ratio, under which the ratio of consolidated total indebtedness to consolidated earnings before interest, taxes, depreciation, amortization and other items specified in the credit agreement (“EBITDA”) may not be greater than 3.50 to 1.00; |
• | a maximum senior secured leverage ratio, under which the ratio of consolidated total secured indebtedness to consolidated EBITDA may not be greater than 2.50 to 1.00; and |
• | a minimum interest coverage ratio, under which the ratio of consolidated EBITDA to consolidated interest expense may not be less than 3.00 to 1.00. |
Consolidated EBITDA as defined in the credit agreement currently is not computed, and in the future may not be computed, in the same manner in which we define “adjusted EBITDA” from time to time for purposes of reports we file with the SEC and present in our other publicly available financial disclosures.
We were in compliance with these financial covenants as of December 31, 2012.
Contractual Obligations
Our 2012 Form 10-K discloses certain commitments and contractual obligations that existed as of March 31, 2012. Our December 2009 acquisition of Southwind Health Partners, L.L.C. and Southwind Navigator, LLC included a contingent obligation to make additional cash and/or common stock payments if certain milestones were met. The contingent obligation has no guaranteed maximum. On October 31, 2012, we transferred 112,408 shares of our common stock to the former owners of the Southwind business to satisfy the component of the contingent obligation payable in our common stock. As of December 31, 2012, $7.1 million has been earned and paid in cash to the former owners. As of December 31, 2012, based on current facts and circumstances, the estimated aggregate fair value of the remaining contingent obligation is $9.4 million, which will be paid at various intervals, if earned, over evaluation periods extending through December 31, 2014.
Our August 2011 acquisition of PivotHealth included a contingent obligation to make additional cash payments if certain revenue targets were achieved over evaluation periods beginning at the acquisition date and extending through December 31, 2014. The contingent obligation has no guaranteed maximum. As of December 31, 2012, the estimated aggregate fair value of the contingent obligation for PivotHealth was $2.9 million.
Our November 2012 acquisition of 360Fresh included a contingent obligation to make additional cash payments if certain revenue targets were achieved over evaluation periods beginning at the acquisition date and extending through August 15, 2014, and which shall not exceed $8 million. As of December 31, 2012, the estimated aggregate fair value of the contingent obligation for 360Fresh was $2.5 million.
Off-Balance Sheet Arrangements
As of December 31, 2012, we had no off-balance sheet financing or other arrangements with unconsolidated entities or financial partnerships (such as entities often referred to as structured finance or special purpose entities) established for purposes of facilitating off-balance sheet financing or other debt arrangements or for other contractually limited purposes.
24
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Interest rate risk.We are exposed to interest rate risk primarily through our portfolio of cash, cash equivalents, and marketable securities, which is designed for safety of principal and liquidity. Cash and cash equivalents include investments in highly liquid U.S. Treasury obligations with maturities of less than three months. As of December 31, 2012, our marketable securities consisted of $114.1 million in tax-exempt notes and bonds issued by various states and $20.6 million in U.S. government-sponsored enterprise securities. The weighted average maturity on all our marketable securities as of December 31, 2012 was approximately 5.7 years. We perform periodic evaluations of the relative credit ratings related to our cash, cash equivalents, and marketable securities. Our portfolio is subject to inherent interest rate risk as investments mature and are reinvested at current market interest rates. We currently do not use derivative financial instruments to adjust our portfolio risk or income profile. Because of the nature of our investments, we have not prepared quantitative disclosure for interest rate sensitivity in accordance with Item 305 of the SEC’s Regulation S-K, as we believe the effect of interest rate fluctuations would not be material.
Foreign currency risk.Our international operations, which account for approximately 3% of our revenue, subject us to risks related to currency exchange fluctuations. Prices for our services sold to members located outside the United States are sometimes denominated in local currencies (primarily British Pound Sterling). As a consequence, increases in the value of the U.S. dollar against local currencies in countries where we have members would result in a foreign exchange loss recognized by us. We recorded foreign currency exchange losses of $63,000 during the three months ended December 31, 2012 and losses of $0.3 million during the nine months ended December 31, 2012, which are included in other income, net in our consolidated statements of income. In the three and nine months ended December 31, 2011, we recorded foreign currency exchange losses of $72,000 and gains of $0.1 million, respectively. A hypothetical 10% change in foreign currency exchange rates would not have had a material impact on our financial position as of December 31, 2012.
Item 4. Controls and Procedures.
Our Chief Executive Officer, or “CEO,” and Chief Financial Officer, or “CFO,” have evaluated the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this quarterly report as required by Rule 13a-15(b) or 15d-15(b) under the Exchange Act.
Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Based on their evaluation, such officers have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures were effective.
During the period covered by this quarterly report, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
As discussed in this report, our actual results could differ materially from the results expressed or implied in our forward-looking statements. There have been no material changes in our risk factors from those described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2012 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
In January 2004, our board of directors authorized the repurchase by us from time to time of up to $50 million of our common stock. That authorization was increased in cumulative amount to $100 million in October 2004, to $150 million in February 2006, to $200 million in January 2007, to $250 million in July 2007, and to $350 million in April 2008. All repurchases have been made in the open market pursuant to this publicly announced repurchase program. No minimum number of shares has been fixed, and the share repurchase authorization has no expiration date. A summary of the share repurchase activity for our third quarter of fiscal 2013 follows:
Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan | |||||||||||||
October 1 to October 31, 2012 | — | $ | — | — | $ | 19,091,319 | ||||||||||
November 1 to November 30, 2012 | 66,562 | $ | 45.06 | 66,562 | $ | 16,091,728 | ||||||||||
December 1 to December 31, 2012 | 43,092 | $ | 46.41 | 43,092 | $ | 14,091,870 | ||||||||||
|
|
|
| |||||||||||||
Total | 109,654 | $ | 45.59 | 109,654 | ||||||||||||
|
|
|
|
25
Table of Contents
As of December 31, 2012, we had repurchased a total of 15,551,661 shares under our repurchase program since the program’s inception.
(a) Exhibits:
31.1 | Certification of the Chief Executive Officer pursuant to Rule13a-14(a) of the Securities Exchange Act of 1934, as amended. | |
31.2 | Certification of the Chief Financial Officer pursuant to Rule13a-14(a) of the Securities Exchange Act of 1934, as amended. | |
32.1 | Certifications pursuant to 18 U.S.C. Section 1350. | |
*101 | XBRL (Extensible Business Reporting Language). The following materials from the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2012, formatted in XBRL: (i) Consolidated Balance Sheets as of December 31, 2012 (unaudited) and March 31, 2012, (ii) Unaudited Consolidated Statements of Income for the Three and Nine Months Ended December 31, 2012 and 2011, (iii) Unaudited Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended December 31, 2012 and 2011, (iv) Unaudited Consolidated Statements of Cash Flows for the Nine months Ended December 31, 2012 and 2011, and (iv) Notes to Unaudited Consolidated Financial Statements. |
* | As provided in Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934. |
26
Table of Contents
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE ADVISORY BOARD COMPANY | ||||||
Date: February 11, 2013 | By: | /s/ Michael T. Kirshbaum | ||||
Michael T. Kirshbaum | ||||||
Chief Financial Officer and Treasurer (Duly Authorized Officer) |
27
Table of Contents
INDEX TO EXHIBITS
Exhibit Number | Description of Exhibit | |
31.1 | Certification of the Chief Executive Officer pursuant to Rule13a-14(a) of the Securities Exchange Act of 1934, as amended | |
31.2 | Certification of the Chief Financial Officer pursuant to Rule13a-14(a) of the Securities Exchange Act of 1934, as amended | |
32.1 | Certifications pursuant to 18 U.S.C. Section 1350 | |
*101 | XBRL (Extensible Business Reporting Language). The following materials from the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2012, formatted in XBRL: (i) Consolidated Balance Sheets as of December 31, 2012 (unaudited) and March 31, 2012, (ii) Unaudited Consolidated Statements of Income for the Three and Nine Months Ended December 31, 2012 and 2011, (iii) Unaudited Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended December 31, 2012 and 2011, (iv) Unaudited Consolidated Statements of Cash Flows for the Nine Months Ended December 31, 2012 and 2011, and (iv) Notes to Unaudited Consolidated Financial Statements. |
* | As provided in Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934. |
28